Loading...
•
Jul 02, 2022
Thermo Fisher Q2 2022 Earnings Report
Thermo Fisher Scientific reported strong financial results driven by core organic revenue growth and strategic investments.
Key Takeaways
Thermo Fisher Scientific reported second quarter revenue of $10.97 billion, an 18% increase year-over-year. GAAP diluted EPS was $4.22, while adjusted EPS was $5.51. The company highlighted its strong financial performance and strategic investments.
Second quarter revenue was $10.97 billion.
Second quarter GAAP diluted earnings per share (EPS) was $4.22.
Second quarter adjusted EPS was $5.51.
Delivered very strong financial results in the second quarter, with 13% Core organic revenue growth and $0.63 billion of COVID-19 testing revenue.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide updated 2022 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern Daylight Time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income